Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-17 ELMS STEVE Director Grant or award · Stock Option (right to buy) +84,411 84,411
2025-11-17 ELMS STEVE Director Grant or award · Stock Option (right to buy) +137,330 137,330
2025-02-12 ELMS STEVE Director Grant or award · Stock Option (right to buy) +30,000 30,000
2024-12-23 ELMS STEVE Director Purchase +11,085 $3.20 $35K 325,370
2023-06-06 ELMS STEVE Director Grant or award · Stock Option (right to buy) +8,000 8,000
2022-05-24 ELMS STEVE Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-06-08 ELMS STEVE Director Grant or award +12,658 29,680
2021-03-16 ELMS STEVE Director Purchase +1,142,857 $1.75 $2.0M 3,142,857
2019-08-06 ELMS STEVE Director Grant or award · Stock Option (right to buy) +12,500 12,500

Page 1 of 1 · 9 trades